Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Invited commentary: Dengue lessons from Cuba.

D W Vaughn1

  • 1Department of Virus Diseases, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA. david.vaughn@na.amedd.army.mil

American Journal of Epidemiology
|November 21, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Workshop on the design and use of clinical trials with multiple endpoints, with a focus on prevention of RSV.

Vaccine: X·2025
Same author

Evaluation of dengue virus strains for human challenge studies.

Vaccine·2014
Same author

Phase 1 studies of Walter Reed Army Institute of Research candidate attenuated dengue vaccines: selection of safe and immunogenic monovalent vaccines.

The American journal of tropical medicine and hygiene·2004
Same author

HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais.

Tissue antigens·2002
Same author

Extinction and rapid emergence of strains of dengue 3 virus during an interepidemic period.

Virology·2002
Same author

TT virus infection in acute non-A to E hepatitis in northern Thailand.

The Southeast Asian journal of tropical medicine and public health·2002
Same journal

A SIMPLE AND POWERFUL TEST OF VACCINE WANING.

American journal of epidemiology·2026
Same journal

Association Between maternal body mass index, offspring growth and pubertal timing: results from a longitudinal birth cohort study.

American journal of epidemiology·2026
Same journal

Maternal Cesarean Section and Offspring ASD or ADHD Risk: A Nurses' Health Study II Analysis.

American journal of epidemiology·2026
Same journal

Immigration and epigenetic age acceleration in the health and retirement study: differences Between Hispanics and Non-Hispanics.

American journal of epidemiology·2026
Same journal

Age-period-cohort analysis of low birth weight, early term delivery, induction and csection, US births 1990-2019.

American journal of epidemiology·2026
Same journal

A measurement comparability study to support instrument harmonization in the Canadian longitudinal study on aging.

American journal of epidemiology·2026
See all related articles

Secondary dengue virus infections, particularly with dengue virus type 2, increase disease severity, supporting the immune enhancement theory. This highlights risks for adults with prior dengue exposure.

Area of Science:

  • Virology
  • Epidemiology
  • Immunology

Background:

  • A significant 18-year gap between dengue virus type 1 and type 2 outbreaks in Cuba offered a unique study setting.
  • The study focused on symptomatic dengue cases, including dengue hemorrhagic fever and fatalities, and asymptomatic seroconversions.

Discussion:

  • The findings provide strong epidemiologic evidence for the immune enhancement theory of dengue pathogenesis.
  • Immune enhancement effects were observed even two decades after initial dengue virus infection.
  • Primary infections with dengue virus type 2 and type 4 appear to be predominantly subclinical.

Key Insights:

  • Adults with prior dengue virus type 1 exposure were at high risk for severe disease during a subsequent dengue virus type 2 outbreak.
  • Nearly all symptomatic cases (98%) resulted from secondary dengue virus infections.

Related Experiment Videos

  • Asymptomatic seroconversions (97%) were primarily associated with primary dengue virus infections.

    • Outlook:

    • The study's observations have critical implications for the development of dengue vaccines, especially live-attenuated viral vaccines.
    • Understanding immune enhancement is crucial for predicting disease outcomes and designing effective prevention strategies.
    • Further research into the long-term effects of primary dengue infections is warranted.